Army testing new malaria drug for deployed troops

Best listening experience is on Chrome, Firefox or Safari. Subscribe to Federal Drive’s daily audio interviews on Apple Podcasts or PodcastOne.

A new drug developed by the Walter Reed Army Institute of Research, called Tafenoquine, has the potential to eradicate malaria. It recently received approval from the Food and Drug Administration. Now the Army is testing how it protects deployed troops. To learn more, Federal News Network’s Eric White spoke with Maj. Victor Zottig, product manager for Tafenoquine at the Army’s Medical Materiel Development Activity, on Federal Drive with Tom Temin.

Copyright © 2020 Federal News Network. All rights reserved. This website is not intended for users located within the European Economic Area.